4
Interleukin-1 (IL-1) family cytokines (e.g. IL-1α, IL-1β, IL-18) play important roles in inflammatory disorders of the gastrointestinal tract 1 . These cytokines undergo proteolytic cleavage to become biologically active 1 . The processing of IL-1 family members IL-1β and IL-18 is mediated by multi-protein complexes, known as "inflammasomes", which can play both beneficial and deleterious roles in the host during infection 2, 3 . At present, five proteins have been shown to form "canonical inflammasomes", with several others awaiting confirmation In turn, ASC interacts with pro-caspase-1 through homotypic caspase-activation recruitment domain (CARD) binding, resulting in cleavage of pro-caspase-1 and subsequent processing of IL-1β/IL-18 into their biologically active forms 2 . Alternatively, inflammasome sensor proteins may bind directly with caspase-1 via CARD-CARD interactions to initiate cytokine processing (e.g.
NLRC4)
2 . These models of canonical inflammasome activation have been developed from studies on IL-1β responses in haematopoietic cells, particularly those of the myeloid cell lineage. In contrast, knowledge regarding inflammasome functions in non-haematopoietic cell lineages, such as epithelial cells, is still poorly understood 3 . It was suggested that inflammasomes in epithelial cells are more likely to be directed at IL- 18 and not IL-1β processing 3 .
IL18 is expressed constitutively in the gastrointestinal tract and is upregulated in response to
infection by the gastric mucosal pathogen, Helicobacter pylori 4, 5, 6 . The role of IL-18 in gastric H.
pylori infection is currently unclear, with both pro-4, 5, 6 and anti-7 inflammatory activities having 5 been assigned to this cytokine. H. pylori generally causes chronic gastritis, but in approximately 1% of cases, infection leads to gastric cancer 8 . Gastric carcinogenesis involves a histological progression from chronically inflamed stomach mucosa, to increasingly severe changes in the glandular epithelium, characterised by atrophic gastritis, intestinal metaplasia and dysplasia, resulting finally in invasive carcinoma 9 .
H. pylori strains that harbour a type IV secretion system (T4SS) are more frequently associated with gastric carcinogenesis than strains lacking this factor 10 . The H. pylori T4SS, which is encoded by the cag pathogenicity island (cagPAI), is essential for induction of nuclear factor κB (NF-κB)-dependent pro-inflammatory responses in epithelial cells 11 . It is now clear that H. pylori strains harbouring a functional T4SS can activate the NF-κB pathway via at least three mechanisms 11 . One of these mechanisms involves sensing by the NLR family member nucleotide-binding oligomerisation domain 1 (NOD1), which is highly expressed in gastric epithelial cells and responds to cell wall peptidoglycan fragments (muropeptides) delivered by the T4SS 12 . Upon activation, NOD1 undergoes self-oligomerisation, leading to the exposure of its CARD and recruitment of the scaffolding kinase protein, receptor-interacting serine-threonine kinase 2 (RIPK2) 13 . This leads to activation of NF-κB and mitogen-activated protein kinase (MAPK) cascades, resulting in cytokine and chemokine production 12, 14, 15 .
Here, we identify a new role for NOD1 in the production of bioactive IL-18 by epithelial cells in response to H. pylori infection. Furthermore, we show that IL-18 plays a protective role in mouse H. pylori infection models and that epithelial cells are the major source of this cytokine in the stomach. Importantly, NOD1-mediated IL-18 processing is independent of the key canonical inflammasome components, NLRP3 and ASC. Instead, NOD1 interacts directly with caspase-1 via CARD-CARD interactions to promote the production of bioactive IL-18. Finally, we show that NOD1 maintains mucosal tissue homeostasis by regulating epithelial cell proliferation and apoptosis. We propose that NOD1-mediated formation of bioactive IL-18 prevents excessive pathology due to chronic H. pylori infection.
Results

Epithelial cells are a major source of IL-18 in the gastric mucosa
IL-18 is expressed by many different tissues throughout the body, including the gastrointestinal tract, where it is produced by epithelial cells, macrophages and dendritic cells 1, 16 . In the stomach, IL-18 expression is constitutive, but is upregulated in response to infection by the pathogenic bacterium, H. pylori 4, 5, 6, 7 . Given this observation, together with the fact that epithelial cells are a major target cell population for H. pylori-host interactions 11 , we sought to investigate inflammasome-mediated processing of IL-18 in epithelial cell responses to H. pylori infection. It was first necessary, however, to demonstrate epithelial cells as a source of IL-18 in the stomach.
For this, we infected mice with H. pylori and then assessed the Il18 expression levels of the gastric cell populations isolated from these animals by fluorescence-activated cell sorting (FACS).
As a comparison, we also measured Il1b expression, because it has a very different expression profile in tissues to that of IL-18 16 . Consistent with studies in mice and humans 4, 5, 6, 7 , we detected constitutive IL-18 production in mice, whereas its production was significantly increased in animals at both 1 and 8 weeks post-infection (p.i.), when compared with control animals given Brain Heart Infusion (BHI) broth alone ( Fig. 1a ; p = 0.03 and p = 0.004, respectively). In contrast, gastric IL-1β production was only increased at 8 weeks p.i. (Fig. 1b; cell-derived IL-18 does not affect IL-1β production nor bacterial colonisation (Fig. 2b, 2c ).
Importantly, mice specifically lacking IL-18 in the non-haematopoietic compartment exhibited increased stomach weights (Fig. 2d) , mucosal thickness (gastric hyperplasia; Fig. 2d , e) and acid mucin production ( Fig. 2f ) when compared with animals producing IL-18 in this compartment.
Consistent with the findings of the BM reconstitution experiments, we also observed that Il18 -/-mice exhibit significantly increased stomach weights at 2 months p.i. with H. pylori, as compared with Il18 +/+ animals ( Supplementary Fig. 1a, 1b) , even though the expression levels of inflammatory cytokine genes, Il1b and Cxcl2, were similar in both groups of animals Supplementary Fig. 1c ). Similar differences in stomach weights between Il18 +/+ and Il18 -/-animals were observed at 13 months p.i. for the related zoonotic Helicobacter sp., Helicobacter felis, which induces greater inflammatory responses than H. pylori in mice 17 ( Supplementary Fig. 1d, 1e ) .
Taken together, our data show that non-haematopoietic cells in the stomach produce IL-18 which plays a protective role against the development of pre-neoplastic lesions during chronic Although all animal groups showed similar levels of bacterial loads (Fig. 3b) , significantly increased inflammatory scores and stomach weights were only observed in Casp1 -/-mice when compared with WT animals ( Fig. 3c, 3d ; p = 0.02). The increased stomach weights observed in the
Casp1
-/-mice are consistent with the findings for Il18 -/-mice ( Fig. 2d, e; Supplementary Fig. 1 ).
Moreover, we infected mice deficient in other known canonical inflammasome molecules, Nlrp1
and Nlrc4, the latter responding to bacterial flagellin and rod proteins 2 , but observed no significant differences in colonisation levels nor stomach pathology when compared with WT animals ( Supplementary Fig. 3 ). Taken together, the findings suggest that the regulation and functions of IL- Supplementary Fig. 5 ), suggesting that NOD1
mediates IL-18 processing in a cell-type-specific manner.
The contribution of NOD1 to IL-18 processing was further investigated in the AGS human gastric epithelial cell line. Interestingly, interfering with NOD1 signalling in AGS cells by either short hairpin RNA (shRNA) knockdown (shNOD1; 14, 22 ) or CRISPR/Cas9 knockout (NOD1 KO; 15 ) resulted in the loss of IL-18 processing in response to H. pylori stimulation (Fig. 4e, 4f) . As the H. pylori T4SS is critical to induction of the NOD1 signalling pathway in AGS cells 12, 14, 15 , we next studied IL-18 processing in response to isogenic H. pylori ΔcagPAI or ΔcagM strains, as well as to the mouse-adapted SS1 strain, all of which lack a functional T4SS 12 . Lower levels of mature IL-18 production were observed in response to these strains when compared with the respective WT (251) and parental human clinical (10700) strain (Fig. 4e) . Thus, H. pylori T4SS activation of the NOD1 signalling pathway is required for IL-18 processing in human gastric epithelial cells.
NOD1 mediates IL-18 processing independently of RIPK2-NF-κB signalling
Classically, NOD1 activation results in the recruitment of the adaptor molecule RIPK2, induction of the NF-κB signalling pathway and upregulation of pro-inflammatory cytokine production 12, 13, 14, 15 .
We therefore investigated the role of RIPK2 in H. pylori-induced IL-18 processing in epithelial cells by small interfering RNA (siRNA) transfection or blocking its activity with the kinase inhibitor, WEHI-345 23 . siRNA-mediated KD of RIPK2 was confirmed by measuring IL-8 production as a read-out for classical NOD1 pathway activation 15 . Surprisingly, blocking RIPK2 signalling had no effect on IL-18 processing in response to H. pylori stimulation in AGS cells ( Fig.   5a , 5b). In agreement with this finding, IL-18 processing was unaffected in both primary gastric epithelial cells and BMDMs from Ripk2 -/-mice, whereas epithelial cell production of the NOD1-regulated chemokines, Cxcl1/keratinocyte chemoattractant (KC) and Cxcl2/macrophage inflammatory protein 2 (MIP2) 12, 24, 25, 26 , was reduced in response to H. pylori stimulation ( Supplementary Fig. 6 ).
To demonstrate that NF-κB activation by NOD1 is dispensable for IL-18 processing in epithelial cells, we restored NOD1 expression in shNOD1 AGS cells with plasmid constructs expressing either WT or a mutant form of NOD1 (K208R NOD1) that is unable to activate NF-κB signalling 19 . As expected, NOD1 shNOD1 AGS cells transfected with plasmid encoding WT NOD1 exhibited significantly higher IL-8 responses to H. pylori stimulation than cells transfected with either the mutant NOD1 or empty control plasmids ( Fig. 5c ; p = 0.03). Conversely, transfection with either WT or mutant NOD1 plasmids was able to rescue IL-18 processing at comparable levels in shNOD1 AGS cells (Fig. 5d ), suggesting that NOD1 mediates gastric epithelial IL-18 processing in an NF-κB independent manner. These findings suggest that H. pylori induces IL-18 processing via a non-classical type of NOD1 signalling pathway.
NOD1 activates caspase-1 to promote IL-18 processing in epithelial cells
It is well established that caspase-1 is a key protease responsible for the cleavage of pro-IL-18 to its mature form in innate immune cells 1, 16 . Therefore, to examine whether NOD1 mediates IL-18
processing in epithelial cells via caspase-1 activation, shNOD1 AGS cells that were transiently expressing yellow fluorescent protein (YFP)-labelled NOD1 were incubated with anti-caspase-1
antibody. As can be observed ( 
NOD1 interacts with caspase-1 via CARD-CARD interactions independently of ASC
We next sought to elucidate potential NOD1-caspase-1 molecular interactions and their involvement in IL-18 processing. It is well established that NLRP3 and AIM2 need the adaptor protein, ASC, to recruit and activate caspase-1. However, as reported above ( Supplementary Fig. 4 ), the AGS cell line does not produce detectable levels of ASC protein, suggesting that NOD1 may directly interact with caspase-1 via homotypic CARD-CARD interactions. This hypothesis was addressed using the fluorescence lifetime imaging microscopy-Förster resonance energy transfer (FLIM-FRET) technique in live cells. For this, we transfected shNOD1 AGS cells with mOrange-NOD1 plasmid (donor alone control) or both mOrange-NOD1 and the acceptor plasmid, encoding EGFP-caspase-1 (Fig. 7a) . We found that H. pylori stimulation led to a significant reduction in the lifetime of the donor fluorochrome, indicative of quenching of the donor by the acceptor EGFPcaspase-1 due to close proximity (< 10 nm) of NOD1 and caspase-1 proteins ( Fig. 7a ; p < 0.0001).
In contrast, the lifetime of the donor remained unchanged in unstimulated cells. These data confirm that NOD1 can directly interact with caspase-1 in response to H. pylori stimulation.
To further examine whether NOD1 interacts with caspase-1 via homotypic CARD-CARD interactions, we performed co-immunoprecipitation assays in which NOD1 KO AGS cells with FLAG-tagged plasmids encoding either full-length NOD1 or NOD1 lacking a CARD domain (ΔCARD NOD1). Full-length and truncated NOD1 proteins were pulled down using anti-FLAG antibodies. Analysis of the resulting immune-complexes revealed that full length NOD1, but not NOD1 lacking a CARD domain, was able to strongly associate with endogenous caspase-1 (Fig.   7b ). Moreover, reconstitution of NOD1 expression with full-length but not CARD-deficient NOD1 rescued H. pylori-induced IL-18 processing in these cells (Fig. 7c) , thus highlighting the important role of the CARD in mediating IL-18 processing. Collectively, the results demonstrate that NOD1
sensing of H. pylori in epithelial cells activates caspase-1 via direct CARD-CARD interactions and independently of ASC, resulting in the processing of IL-18.
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NOD1 maintains epithelial homeostasis in response to H. pylori infection
As IL-18 appeared to be important for protecting tissues against excessive pathology during chronic H. pylori infection in vivo (Fig. 2, Supplementary Fig. 1 (Fig. 8c) . Consistent with data for AGS cells (Fig. 2a, b Intestinal epithelial cells constitutively produce IL-18, suggesting that epithelial inflammasomes have a "ready-to-go" phenotype that allows rapid responses to pathogens and other damage to the gut 3, 29 .
In agreement with this suggestion, we (Fig. 4, 5 , but was unable to determine the relative contributions of these cells to IL-18 production in vivo. Our data provide unequivocal evidence that epithelial cells are a major source of IL-18 production in the stomach during H. pylori infection (Fig. 1c, d; 2, a, b) .
Using primary and immortalised epithelial cells, we show that these cells can also process IL-18 to its mature form (Fig. 4b, d-f 39, 40 . Similarly, we observed NLRP3-dependent regulation of IL-1β and IL-18 responses in BMDMs ( Supplementary Fig. 2 ), however, no role could be found for this inflammasome, nor for its adaptor ASC, in IL-18 production by primary mouse gastric epithelial cells (Fig. 3a) . H. pylori upregulated IL-18 production and processing in the human AGS gastric epithelial line (Fig. 4e, f, 5d ) which, contrary to previous reports 43, 44 , does not appear to express either NLRP3 or ASC ( Supplementary Fig. 4 and unpublished data). Another study also reported that AGS cells do not produce ASC 6 . Consistent with these data, no differences in H. pylori bacterial loads or resulting inflammation were observed in Nlrp3 -/-or Pycard -/-mice when compared with WT animals (Fig. 3b-d) . One group reported increased bacterial loads and decreased gastric inflammation in Nlrp3 -/-mice 42 , whereas the complete opposite was reported in another study 38 . The reasons for the divergent results between these three studies are unclear but may stem 16 from differences in the composition of the mouse microbiota and not to the bacterial strains used, as the latter two studies used the same strain i. e. H. pylori 10700 (PMSS1). Notwithstanding the different findings, the data presented here clearly establish that the canonical NLRP3/ASC inflammasome is not required for gastric epithelial cell production of IL-18 responses to H. pylori infection ( Fig. 3; 4e, f) . In addition, the inflammasome protein NLRC4 does not seem to play a significant role in the infection (Fig. Supplementary Fig. 3g, h ). This finding is compatible with the known inability of H. pylori 42 or its flagellin 45 to promote caspase-1 processing and IL-1β secretion in macrophages.
A key and novel discovery of the current work is the observation that NOD1 interacts with caspase-1 to mediate H. pylori induction of IL-18 processing in epithelial cells. Interestingly, this
IL-18 processing occurs independently of CARD-CARD interactions between NOD1 and its
adapter molecule, RIPK2 (Fig. 5) . Early studies in the field reported NOD1 interactions with caspase-1 19, 46 , resulting in IL-1β secretion in cells 46 . A caveat to those studies, however, is that they were undertaken using over-expression approaches which can be susceptible to experimental artefacts. We now provide several lines of supportive evidence to show that NOD1 interacts with caspase-1 to mediate tissue protective IL-18 responses in epithelial cells. Firstly, we have confirmed the findings of previous investigations by performing similar over-expression and classical protein "pulldown" experiments (Fig. 7b, c) and used fluorescence and FLIM-FRET imaging to show close interactions between NOD1 and caspase-1 in response to H. pylori stimulation (Fig. 6a, b; Fig. 7a) .
Secondly, we demonstrate that caspase-1 processing is itself dependent on NOD1 activation (Fig. 4,   6c ). Thirdly, we show that IL-18 production is abrogated in primary gastric epithelial cells from
Casp1
-/-mice ( Fig. 3a) and in cells pre-treated with the caspase-1 inhibitor, Z-YVAD (Fig. 6d) .
Finally, Casp1 -/-mice infected with H. pylori reproduce aspects of the severe pathology observed in
Il18
-/-animals ( Fig. 3b-d ) and is consistent with the enhanced inflammatory changes also observed in Casp1 -/-mice infected with H. felis 7 .
NLRs were originally identified for their roles in host defence and inflammation. However, more recent work in colitis models has shown that these proteins also play important roles in tissue repair and the maintenance of homeostasis. NLRs were shown to mediate these protective effects via various mechanisms, including the production of antimicrobial peptides, control of the gut microbiota 28, 30 Fig. 7 ) and WT mice were bred at the Animal Research Facility, Monash Medical Centre (MMC). KO mice had been backcrossed at least ten generations on the C57BL/6J background and maintained under specific pathogen-free conditions in micro-isolator cages with access to food and water ad libitum.
Experiments were performed using age-and sex-matched animals. Mouse primary gastric epithelial cells 15 and BMDMs 52 were isolated, as described previously. The human AGS gastric cancer cells stably expressing shRNA to either EGFP (shEGFP) or NOD1 (shNOD1) were generated as described previously 22 . Human NOD1 KO and control AGS cells were generated by CRISPR Cas/9 technology and their KO status validated previously 15 . AGS cells were maintained in complete RPMI medium supplemented with 10% (v/v) foetal calf serum (FCS), 1% (w/v) L-glutamine and 1 % (w/v) penicillin/streptomycin (Gibco; ThermoFisher Scientific, VIC, Australia).
The mouse GSM06 GEC line (Riken Cell Bank RCB1779) was grown as described previously 20 . Briefly, the cells were maintained in Dulbecco's modified Eagle medium-nutrient mixture/F-12 medium, supplemented with 10% FCS, 1% (w/v) insulin/transferring/selenite (Gibco) and 10 ng/ml epidermal growth factor. Cells were grown in 5% CO 2 at the permissive temperature of 33˚C, then moved to 37˚C prior to experiments. BM reconstitution experiments were performed by subjecting recipient mice to two 5.5-Gy doses of irradiation given 3 hr apart and then injecting 1 × 10 6 donor bone marrow cells via intravenous injection 52 . At 6 weeks post-transfer, recipient mice were infected with H. pylori SS1 and sacrificed at 5 and 18 weeks p.i.
Inhibitor treatment
Cells were pre-treated with ML130 (5 μM; CID-1088438; Tocris, UK) 21 , WEHI-345 (0, 5 or 10 μM) 23 or Z-YVAD-fmk (0, 1, 5 and 10 μM; 21874; Merck, Australia) for 1 hr prior to stimulation with H. pylori, then maintained in inhibitor-containing medium throughout the experiment.
Histological analysis
Gastric tissues were formalin-fixed and embedded in paraffin. Tissues were stained with Mayer's
Haematoxylin & Eosin or Periodic acid-Schiff (PAS)-Alcian Blue (AB) stains and imaged at 20 x magnification using a bright-field microscope (Nikon). Inflammatory scores for neutrophils and lymphocytes were graded in a blinded fashion (JSP) according to a previously described grading scheme 20 . The mucosal thickness of stomach tissues was determined in a blinded fashion (JE) on sections that had been digitised using an Aperio slide scanner (Leica Biosystems, VIC, Australia)
and ImageScope software (Leica Biosystems). Three measurements were taken for each tissue section, with 3-4 sections available per stomach sample.
Immunofluorescence
Antigen retrieval was performed by immersion in 10 mM sodium citrate buffer (pH 6) and boiling 
Cell transfection
DNA plasmids (Caspase-1-GFP and NOD1-mOrange) 59 or specific silencer and negative control 
Co-immunoprecipitation
Cells were seeded at 2 x 10 5 cell/ml in 10 cm dishes and left to rest overnight. DNA (4 μ g) of plasmid constructs encoding either FLAG-tagged full-length NOD1 (NOD1-FLAG) or NOD1 lacking a CARD domain (ΔCARD NOD1-FLAG) 59 was diluted in 1 ml of Opti-MEM medium anti-rabbit secondary antibody-Alex Fluor ® 800 (0.67 ng/ml; ThermoFisher Scientific). Membranes were washed and developed on the Odyssey Infrared Imaging System (LI-COR). As loading controls, lysate samples were probed with rat-anti-human Tubulin (0.9 ng/ml; Rockland, PA, USA),
followed by goat-anti-rat secondary antibody-Alexa Fluor ® 800 conjugate (0.33 ng/ml; ThermoFisher Scientific).
Quantitative PCR (qPCR) analyses
RNA was extracted from cells using the PureLink® RNA mini kit (ThermoFisher Scientific).
cDNA was generated from 500 μ g of RNA using the Tetro cDNA synthesis kit (Bioline, 
Organoid cultures and microinjection
Gastric organoids were generated using an adaptation of previously described methods 60 . Briefly, mouse stomachs were dissected, cut open along the greater curvature, and washed thoroughly with PBS. The outer muscle layer was removed using fine-tipped forceps and the forestomach discarded.
The remaining tissue was cut into 2 mm pieces and washed in cold PBS before digestion with 10 mM EDTA for 4 hr at 4°C. To isolate glands, tissue fragments were vigorously suspended in cold PBS using 10 ml pipettes and the supernatants were collected. This procedure was repeated a total of three times. Crypts were pelleted by centrifugation at 240 x g for 5 min, at 4°C. Pellets were resuspended in PBS, passed through cell strainers (70 µm; Falcon) and centrifuged. Supernatants were discarded and the pellets containing the glands were resuspended in Matrigel (Corning).
Matrigel was seeded into each well of a 24-well plate (Nunc) and incubated for 10 min at 37°C until solidified. Crypt culture media (DMEM/F12 (Gibco), B27 (Gibco), Glutamax (Gibco), N2 (Gibco), 10 mM HEPES (Gibco), N-acetyl cysteine (1.25 µM; Sigma Aldrich), EGF (50 ng/ml; Peprotech), Noggin (100 ng/ml; Peprotech), Gastrin (10 nM; Sigma Aldrich), FGF10 (100 ng/ml; Peprotech),
27
10% (v/v) R-spondin 1-conditioned media, and 50% (v/v) Wnt3a-conditioned media) was added to each well. Established organoids were microinjected with 20 nl of overnight culture H. pylori suspension (10 7 bacteria/ml) using the IM-300 pneumatic microinjector (Narishige). The presence of bacteria in the organoids was confirmed by immunofluorescence staining with rabbit anti-H.
pylori antibody (in-house) and anti-cadherin (5 μg/ml; clone DECMA-1, Abcam), followed by the appropriate secondary antibodies. Organoid viability was assessed using PrestoBlue reagent (Life Technologies). Cell proliferation and apoptosis in the organoids were assessed using the MTT assay and Annexin V/PI straining, respectively. Representative data for three independent experiments (a-d). Significance was determined by the unpaired two-tailed t-test (c). NS = not significant. Data correspond to the mean ± SEM. Representative data for two independent experiments. 
